January 15, 2026
Based on market forecasts, the dermatology sector will expand from USD 1.51 billion in 2025 to USD 2.95 billion by 2035, experiencing a CAGR of 6.94%. In 2024, Asia-Pacific led the global dermatology market, while North America is set for the fastest...
January 09, 2026
Based on our market forecasts, the dermatology and plastic surgery sector will expand from USD 42.96 billion in 2025 to USD 101.69 billion by 2035, experiencing a CAGR of 9%. The rising prevalence of skin disorders and the need for aesthetic appearan...
April 21, 2026
According to market projections, the U.S. dermatology sector is expected to grow from USD 514.58 million in 2024 to USD 1041.01 million by 2034, reflecting a CAGR of 7.3%. In 2024, cosmetic dermatology led the U.S. dermatology market by product type,...
September 22, 2026
According to Payal Rabde, who specializes in topical products used to prevent, treat, and manage skin disorders in animals, including infections, allergies, inflammation, wounds, and parasitic conditions, with 4+ years of experience in market researc...
February 26, 2026
Based on our market research, the AI in medical scribing market was valued at USD 1.39 billion in 2025 and is projected to grow from USD 1.67 billion in 2026 to USD 8.93 billion by 2035, expanding at a CAGR of 20.48% (2026–2035)....
February 17, 2026
According to our forecasts, the drug delivery CDMO market is set for strong growth from 2026 to 2035, driven by rising chronic diseases, expanding biologics and GLP-1 therapies, and increasing outsourcing by pharmaceutical and biotech companies....
March 11, 2026
According to forecasts, the United States wound care centers market will grow from USD 16.1 billion in 2025 to USD 26.6 billion by 2035, with an expected CAGR of 5.15%. The U.S. wound care centers market is growing due to more chronic wounds, an agin...
August 14, 2026
Payal Rabde is a Healthcare Market Research Analyst specializing in the U.S. dermatology CRO market. She tracks the growing incidence of dermatological disorders, increasing treatment pipeline, diagnostic needs, funding support, and novel drug ap...
+1 9197 992 333
+91 93077 85324
